Noninvasive monitoring of immunosuppressive drug efficacy to prevent rejection of intracerebral glial precursor allografts

Cell Transplantation

Volumn 21, Issue 10, 2012, Pages 2149-2157

  Gorelik, Michael ^a   Janowski, Miroslaw ^a,b   Galpoththawela, Chulani ^a   Rifkin, Robert ^a   Levy, Michael ^a   Lukomska, Barbara ^b   Kerr, Douglas A ^c   Bulte, Jeff W M ^a   Walczak, Piotr ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c BIOGEN   (United States)

Author keywords

Allograft; Bioluminescence; Glial restricted precursors; Immunosuppression; Rejection; Transplantation

Indexed keywords

CYCLOSPORIN A; RAPAMYCIN; TACROLIMUS;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFICACY; DRUG MONITORING; FEMALE; GLIA CELL; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNITY; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE; MOUSE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ANIMALS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEUROGLIA;

ANIMALIA; MUS;

EID: 84870449390     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X636911     Document Type: Article

References (46)

1. Apostolou, E.; Hochedlinger, K. Stem cells: iPS cells under attack. Nature 474(7350):165-166; 2011.
2. Armstrong, R. J.; Hurelbrink, C. B.; Tyers, P.; Ratcliffe, E. L.; Richards, A.; Dunnett, S. B.; Rosser, A. E.; Barker, R. A. The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease. Exp. Neurol. 175(1):98-111; 2002.
3. Barker, R. A.; Widner, H. Immune problems in central nervous system cell therapy. NeuroRx 1(4):472-481; 2004.
4. Ben-Hur, T.; Goldman, S. A. Prospects of cell therapy for disorders of myelin. Ann. N. Y. Acad. Sci. 1142:218-249; 2008.
5. Bergwerf, I.; De Vocht, N.; Tambuyzer, B.; Verschueren, J.; Reekmans, K.; Daans, J.; Ibrahimi, A.; Van Tendeloo, V.; Chatterjee, S.; Goossens, H.; Jorens, P. G.; Baekelandt, V.; Ysebaert, D.; Van Marck, E.; Berneman, Z. N.; Linden, A. V.; Ponsaerts, P. Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice. BMC Biotechnol. 9:1; 2009.
6. Berman, S. C.; Galpoththawela, C.; Gilad, A. A.; Bulte, J. W.; Walczak, P. Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn. Reson. Med. 65(2):564-574; 2011.
7. Bradbury, M. S.; Panagiotakos, G.; Chan, B. K.; Tomishima, M.; Zanzonico, P.; Vider, J.; Ponomarev, V.; Studer, L.; Tabar, V. Optical bioluminescence imaging of human ES cell progeny in the rodent CNS. J. Neurochem. 102(6):2029-2039; 2007.
8. Branchini, B. R.; Ablamsky, D. M.; Davis, A. L.; Southworth, T. L.; Butler, B.; Fan, F.; Jathoul, A. P.; Pule, M. A. Red-emitting luciferases for bioluminescence reporter and imaging applications. Anal. Biochem. 396(2):290-297; 2010.
9. Chang, M. H.; Cirillo, S. L.; Cirillo, J. D. Using luciferase to image bacterial infections in mice. J. Vis. Exp. 48:2547; 2011.
10. Chen, C. H.; Yeh, Y. C.; Wu, G. J.; Huang, Y. H.; Lai, W. F.; Liu, J. Y.; Tzeng, C. R. Tracking the rejection and survival of mouse ovarian iso- and allografts in vivo with bioluminescent imaging. Reproduction 140(1):105-112; 2010.
11. Chen, X.; Zhang, X.; Larson, C.; Xia, G.; Kaufman, D. B. Prolonging islet allograft survival using in vivo bioluminescence imaging to guide timing of antilymphocyte serum treatment of rejection. Transplantation 85(9):1246-1252; 2008.
12. Chen, X.; Zhang, X.; Larson, C. S.; Baker, M. S.; Kaufman, D. B. In vivo bioluminescence imaging of transplanted islets and early detection of graft rejection. Transplantation 81(10):1421-1427; 2006.
13. Chen, Z.; Palmer, T. D. Cellular repair of CNS disorders: An immunological perspective. Hum. Mol. Genet. 17(R1):R84-92; 2008.
14. Chewning, J. H.; Dugger, K. J.; Chaudhuri, T. R.; Zinn, K. R.; Weaver, C. T. Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model. BMC Immunol. 10:44; 2009.
15. Daadi, M. M.; Li, Z.; Arac, A.; Grueter, B. A.; Sofilos, M.; Malenka, R. C.; Wu, J. C.; Steinberg, G. K. Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol. Ther. 17(7):1282-1291; 2009.
16. Freed, C. R.; Greene, P. E.; Breeze, R. E.; Tsai, W. Y.; DuMouchel, W.; Kao, R.; Dillon, S.; Winfield, H.; Culver, S.; Trojanowski, J. Q.; Eidelberg, D.; Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344(10):710-719; 2001.
17. Ideguchi, M.; Shinoyama, M.; Gomi, M.; Hayashi, H.; Hashimoto, N.; Takahashi, J. Immune or inflammatory response by the host brain suppresses neuronal differentiation of transplanted ES cell-derived neural precursor cells. J. Neurosci. Res. 86(9):1936-1943; 2008.
18. Janowski, M.; Walczak, P.; Date, I. Intravenous route of cell delivery for treatment of neurological disorders: A meta-analysis of preclinical results. Stem Cells Dev. 19(1):5-16; 2010.
19. Kondziolka, D.; Steinberg, G. K.; Wechsler, L.; Meltzer, C. C.; Elder, E.; Gebel, J.; Decesare, S.; Jovin, T.; Zafonte, R.; Lebowitz, J.; Flickinger, J. C.; Tong, D.; Marks, M. P.; Jamieson, C.; Luu, D.; Bell-Stephens, T.; Teraoka, J. Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. J. Neurosurg. 103(1):38-45; 2005.
20. Kondziolka, D.; Wechsler, L.; Goldstein, S.; Meltzer, C.; Thulborn, K. R.; Gebel, J.; Jannetta, P.; DeCesare, S.; Elder, E. M.; McGrogan, M.; Reitman, M. A.; Bynum, L. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55(4):565-569; 2000.
21. Kwon, H.; Enomoto, T.; Shimogawara, M.; Yasuda, K.; Nakajima, Y.; Ohmiya, Y. Bioluminescence imaging of dual gene expression at the single-cell level. Biotechniques 48(6):460-462; 2010.
22. Lepore, A. C.; Walczak, P.; Rao, M. S.; Fischer, I.; Bulte, J. W. MR imaging of lineage-restricted neural precursors following transplantation into the adult spinal cord. Exp. Neurol. 201(1):49-59; 2006.
23. Li, S. H.; Lai, T. Y.; Sun, Z.; Han, M.; Moriyama, E.; Wilson, B.; Fazel, S.; Weisel, R. D.; Yau, T.; Wu, J. C.; Li, R. K. Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery. J. Thorac. Cardiovasc. Surg. 137(5):1225-1233; 2009.
24. Ma, N. Q.; Liu, L. L.; Min, J.; Wang, J. W.; Jiang, W. F.; Liu, Y.; Feng, Y. G.; Su, H. C.; Feng, Y. M.; Zhang, H. L. The effect of down regulation of calcineurin Aalpha by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis. Clin. Exp. Metastasis 28(8):765-778; 2011.
25. Okada, S.; Ishii, K.; Yamane, J.; Iwanami, A.; Ikegami, T.; Katoh, H.; Iwamoto, Y.; Nakamura, M.; Miyoshi, H.; Okano, H. J.; Contag, C. H.; Toyama, Y.; Okano, H. In vivo imaging of engrafted neural stem cells: Its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J. 19(13):1839-1841; 2005.
26. Olanow, C. W.; Goetz, C. G.; Kordower, J. H.; Stoessl, A. J.; Sossi, V.; Brin, M. F.; Shannon, K. M.; Nauert, G. M.; Perl, D. P.; Godbold, J.; Freeman, T. B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54(3):403-414; 2003.
27. O'Neill, K.; Lyons, S. K.; Gallagher, W. M.; Curran, K. M.; Byrne, A. T. Bioluminescent imaging: A critical tool in preclinical oncology research. J. Pathol. 220(3):317-327; 2010.
28. Patel, M. R.; Chang, Y. F.; Chen, I. Y.; Bachmann, M. H.; Yan, X.; Contag, C. H.; Gambhir, S. S. Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects. Cancer Res. 70(24):10141-10149; 2010.
29. Rabinovich, B. A.; Ye, Y.; Etto, T.; Chen, J. Q.; Levitsky, H. I.; Overwijk, W. W.; Cooper, L. J.; Gelovani, J.; Hwu, P. Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc. Natl. Acad. Sci. USA 105(38):14342-14346; 2008.
30. Roda, A.; Cevenini, L.; Michelini, E.; Branchini, B. R. A portable bioluminescence engineered cell-based biosensor for on-site applications. Biosens. Bioelectron. 36(8):3647-3653; 2011.
31. Rota Nodari, L.; Ferrari, D.; Giani, F.; Bossi, M.; Rodriguez-Menendez, V.; Tredici, G.; Delia, D.; Vescovi, A. L.; De Filippis, L. Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression. PLoS One 5(11):e14035; 2010.
32. Sato, A.; Klaunberg, B.; Tolwani, R. In vivo bioluminescence imaging. Comp. Med. 54(6):631-634; 2004.
33. Shi, X.; Kang, Y.; Hu, Q.; Chen, C.; Yang, L.; Wang, K.; Chen, L.; Huang, H.; Zhou, C. A long-term observation of olfactory ensheathing cells transplantation to repair white matter and functional recovery in a focal ischemia model in rat. Brain Res. 1317:257-267; 2010.
34. Soderstrom, K. E.; Meredith, G.; Freeman, T. B.; McGuire, S. O.; Collier, T. J.; Sortwell, C. E.; Wu, Q.; Steece-Collier, K. The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors. Neurobiol. Dis. 32(2):229-242; 2008.
35. Strauss, S. Geron trial resumes, but standards for stem cell trials remain elusive. Nat. Biotechnol. 28(10):989-990; 2010.
36. Swijnenburg, R. J.; Schrepfer, S.; Govaert, J. A.; Cao, F.; Ransohoff, K.; Sheikh, A. Y.; Haddad, M.; Connolly, A. J.; Davis, M. M.; Robbins, R. C.; Wu, J. C. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl. Acad. Sci. USA 105(35):12991-12996; 2008.
37. Takahashi, Y.; Tsuji, O.; Kumagai, G.; Hara, C. M.; Okano, H. J.; Miyawaki, A.; Toyama, Y.; Okano, H.; Nakamura, M. Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice. Cell Transplant. 20(5):727-739; 2011.
38. Tambuyzer, B. R.; Bergwerf, I.; De Vocht, N.; Reekmans, K.; Daans, J.; Jorens, P. G.; Goossens, H.; Ysebaert, D. K.; Chatterjee, S.; Van Marck, E.; Berneman, Z. N.; Ponsaerts, P. Allogeneic stromal cell implantation in brain tissue leads to robust microglial activation. Immunol. Cell Biol. 87(4):267-273; 2009.
39. Tolar, J.; O'Shaughnessy, M. J.; Panoskaltsis-Mortari, A.; McElmurry, R. T.; Bell, S.; Riddle, M.; McIvor, R. S.; Yant, S. R.; Kay, M. A.; Krause, D.; Verfaillie, C. M.; Blazar, B. R. Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells. Blood 107(10):4182-4188; 2006.
40. Toriumi, H.; Yoshikawa, M.; Matsuda, R.; Nishimura, F.; Yamada, S.; Hirabayashi, H.; Nakase, H.; Nonaka, J.; Ouji, Y.; Ishizaka, S.; Sakaki, T. Treatment of Parkinson's disease model mice with allogeneic embryonic stem cells: Necessity of immunosuppressive treatment for sustained improvement. Neurol. Res. 31(3):220-227; 2009.
41. van Os, R.; Ausema, A.; Dontje, B.; van Riezen, M.; van Dam, G.; de Haan, G. Engraftment of syngeneic bone marrow is not more efficient after intrafemoral transplantation than after traditional intravenous administration. Exp. Hematol. 38(11):1115-1123; 2010.
42. Walczak, P.; All, A. H.; Rumpal, N.; Gorelik, M.; Kim, H.; Maybhate, A.; Agrawal, G.; Campanelli, J. T.; Gilad, A. A.; Kerr, D. A.; Bulte, J. W. Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination. Glia 59(3):499-510; 2011.
43. Walczak, P.; Chen, N.; Hudson, J. E.; Willing, A. E.; Garbuzova-Davis, S. N.; Song, S.; Sanberg, P. R.; Sanchez-Ramos, J.; Bickford, P. C.; Zigova, T. Do hematopoietic cells exposed to a neurogenic environment mimic properties of endogenous neural precursors? J. Neurosci. Res. 76(2):244-254; 2004.
44. Windrem, M. S.; Schanz, S. J.; Guo, M.; Tian, G. F.; Washco, V.; Stanwood, N.; Rasband, M.; Roy, N. S.; Nedergaard, M.; Havton, L. A.; Wang, S.; Goldman, S. A. Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell 2(6):553-565; 2008.
45. Xu, L.; Xu, C. J.; Lu, H. Z.; Wang, Y. X.; Li, Y.; Lu, P. H. Long-term fate of allogeneic neural stem cells following transplantation into injured spinal cord. Stem Cell Rev. 6(1):121-136; 2010.
46. Yan, J.; Xu, L.; Welsh, A. M.; Chen, D.; Hazel, T.; Johe, K.; Koliatsos, V. E. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 24(8):1976-1985; 2006.